<SEC-DOCUMENT>0001157523-22-000053.txt : 20220112
<SEC-HEADER>0001157523-22-000053.hdr.sgml : 20220112
<ACCEPTANCE-DATETIME>20220112071511
ACCESSION NUMBER:		0001157523-22-000053
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20220112
FILED AS OF DATE:		20220112
DATE AS OF CHANGE:		20220112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICON PLC
		CENTRAL INDEX KEY:			0001060955
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				981067160

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-08704
		FILM NUMBER:		22525574

	BUSINESS ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000
		BUSINESS PHONE:		00 353 1 291 2000

	MAIL ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ICON PLC  /ADR/
		DATE OF NAME CHANGE:	20010213
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a52561668.htm
<DESCRIPTION>ICON PLC 6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Business Wire
         Document created using EDGARfilings PROfile 8.0.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">&#160;FORM 6-K</div>
    <div style="text-align: center;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">SECURITIES AND
      EXCHANGE COMMISSION</div>
    <div><br>
    </div>
    <div style="text-align: center;">Washington, D.C. 20549</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">Report of Foreign Private Issuer</div>
    <div style="text-align: center; font-weight: bold;">Pursuant to Rule 13a-16 under</div>
    <div style="text-align: center;">t<font style="font-weight: bold;">he Securities Exchange Act of 1934</font></div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center;">For the month ended January, 2022</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">ICON plc</div>
    <div style="text-align: center;">(Registrant's name)</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">333-08704</div>
    <div style="text-align: center;">&#160;(Commission file number)</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center;">South County Business Park, Leopardstown, Dublin 18, Ireland</div>
    <div style="text-align: center;">(Address of principal executive offices)</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center;">Brendan Brennan, CFO</div>
    <div style="text-align: center;">South County Business Park, Leopardstown, Dublin 18, Ireland.</div>
    <div style="text-align: center;">Brendan.Brennan@iconplc.com</div>
    <div style="text-align: center;">+353-1-291-2000</div>
    <div style="text-align: center;">&#160;(Name, telephone number, email and/or facsimile number and address of Company contact person)</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6e6324795e3f48b9876701d559f61c26">

        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">&#160;</td>
          <td style="width: 17%; vertical-align: top;">
            <div>Form 20-F_X___</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>Form 40-F_______</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div>&#160;</div>
          </td>
          <td style="width: 17%; vertical-align: top;">
            <div>Yes______</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>No___<font style="font-weight: bold;">X</font>___</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div>&#160;</div>
          </td>
          <td style="width: 17%; vertical-align: top;">
            <div>Yes______</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>No___<font style="font-weight: bold;">X</font>___</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule12g3-2(b) under the Securities Exchange Act of 1934.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div>&#160;</div>
          </td>
          <td style="width: 17%; vertical-align: top;">
            <div>Yes______</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>No___<font style="font-weight: bold;">X</font>___</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):82 <font style="font-weight: bold;">N/A</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <br>
    <div style="text-align: center; font-weight: bold;"><u>EXHIBIT LIST</u></div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zfacef67a418743caa6320a42cce49821">

        <tr>
          <td style="width: 12.95%; vertical-align: top;">
            <div><u>Exhibit</u></div>
          </td>
          <td style="width: 1.04%; vertical-align: top;">
            <div>&#160;</div>
          </td>
          <td style="width: 85.92%; vertical-align: top;">
            <div><u>Description</u></div>
          </td>
        </tr>
        <tr>
          <td style="width: 12.95%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 1.04%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 85.92%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12.95%; vertical-align: top;">
            <div><a href="a52561668ex99_1.htm">99.1</a></div>
          </td>
          <td style="width: 1.04%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 85.92%; vertical-align: top;">
            <div><a href="a52561668ex99_1.htm">ICON Issues Financial Guidance for Full Year 2022</a></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <br>
    <div style="text-align: center; font-weight: bold;">SIGNATURES</div>
    <div><br>
    </div>
    <div>Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</div>
    <div>&#160;</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z688d1639d8f14228927bc3f318ef5d3e">

        <tr>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div style="font-weight: bold;">ICON plc</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle; border-bottom: #000000 2px solid;">
            <div>/s/ Brendan Brennan</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: top;">
            <div>Date: January 12, 2022</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>Brendan Brennan</div>
            <div>Chief Financial Officer</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <br>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a52561668ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Business Wire
         Document created using EDGARfilings PROfile 8.0.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <table cellspacing="0" cellpadding="0" border="0" id="zf31a8a4e7a574174aaf2af44cc062ee6" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

        <tr>
          <td style="width: 100%; text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <div class="bw-release">
      <h1 style="text-align: center; list-style-position: inside;FONT-SIZE: 14pt;"> <b>ICON Issues Financial Guidance for Full Year 2022</b> </h1>
      <div class="bw-release-subhead">
        <p><b> <b>Highlights</b> </b></p>
        <ul style="list-style-type: disc;">
          <b>
            <li> Full Year 2022 Revenue guidance in the range of $7,770 - $8,050 million, representing growth of 43 &#8211; 46% over Full Year 2021 Revenue guidance. </li>
            <li> Full Year 2022 adjusted earnings per share guidance in the range of $11.55 - $11.95, representing growth of 21 &#8211; 23% over Full Year 2021 adjusted earnings per share guidance. </li>
            <li> Reaffirming 2021 guidance of revenue in the range of $5,430 - $5,530 million and adjusted earnings per share in the range of $9.55 - $9.75. </li>
          </b>
        </ul>
      </div>
      <div class="bw-release-body">
        <div class="bw-release-table-js bw-release-story">
          <p>DUBLIN--(BUSINESS WIRE)--January 12, 2022--ICON plc,<b> (NASDAQ: ICLR),</b> a world-leading clinical research organisation powered by healthcare intelligence, today announced its financial guidance for the year ended December 31, 2022. For the
            full year 2022, revenue is expected to be in the range of $7,770 - $8,050 million, representing growth of 43 &#8211; 46% and adjusted earnings per share is expected to be in the range of $11.55 - $11.95, representing growth of 21 &#8211; 23%, over Full
            Year 2021 revenue and adjusted earnings per share guidance, respectively. Adjusted earnings per share to exclude amortization, stock compensation, foreign exchange and transaction-related / integration-related adjustments. </p>
          <p> CEO Steve Cutler commented, &#8220;<i>As the world&#8217;s largest and most comprehensive CRO, ICON is well positioned to lead the market as the healthcare intelligence partner of choice in clinical development.</i> <i>We saw strong demand from
              customers that resulted in a trailing twelve month book to bill of 1.3x and total backlog of $18.6 billion at the end of the third quarter 2021. With our solid performance in 2021 coupled with continued strength in the broader industry
              environment, we expect growth of 43 &#8211; 46% in revenue to a range of $7,770 - $8,050 million and adjusted earnings per share to increase by 21 &#8211; 23% to a range of $11.55 - $11.95 for the full year 2022.&#8221;</i> </p>
          <p> The full year 2022 financial guidance assumes: </p>
          <ul style="list-style-type: disc;">
            <li> US dollar to Euro exchange rate of $1.15. </li>
            <li> An effective tax rate of circa 16.5%. </li>
            <li> Days Sales Outstanding of circa 25 - 30 days. </li>
            <li> Circa $1bn free cash flow and capital expenditures of circa $150 million. </li>
            <li> No share repurchase or M&amp;A activity included in the above guidance. </li>
          </ul>
          <p> With respect to 2021, the company reaffirmed its current guidance of revenue in the range of $5,430 - $5,530 million and adjusted earnings per share in the range of $9.55 - $9.75. </p>
          <p> <b>About ICON plc</b> </p>
          <p> ICON plc is a world-leading clinical research organisation powered by healthcare intelligence. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and
            government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 37,960 employees in 159 locations in 53
            countries as at September 30, 2021. For further information about ICON, visit: www.iconplc.com. </p>
          <div> </div>
          <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" id="DSPFPageBreakArea">
            <div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
              <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
          </div>
          <p> This press release contains forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not
            guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties
            and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new
            offices and offering of new services, the integration of new business mergers and acquisitions, the impact of COVID-19 on our business, as well as other economic and global market conditions and other risks and uncertainties detailed from time
            to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions.
            The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update
            publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by
            ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov. </p>
          <p> Source: ICON plc </p>
          <p> <strong>ICON/ICLR-F</strong> </p>
        </div>
        <div class="bw-release-contact">
          <h2 style="FONT-SIZE: 14pt;">Contacts</h2>
          <p> Investor Relations 1 888 381 7923 <br>
            <br>
            Brendan Brennan Chief Financial Officer + 353 1 291 2000 <br>
            <br>
            Kate Haven Vice President Investor Relations +1 888 381 7923 </p>
        </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
